Literature DB >> 2120838

[Initial therapy of acute unilateral epididymitis using ofloxacin. I. Clinical and microbiological findings].

W Weidner1, C Garbe, L Weissbach, J Harbrecht, K Kleinschmidt, H G Schiefer, H J Friedrich.   

Abstract

In a prospective study, 70 men suffering from uncomplicated acute unilateral epididymitis were treated initially with 2 x 200 mg ofloxacin p.o. per day for 14 days. Patients were reexamined at the end of therapy and again after 6 and 12 weeks. Patients were retreated when the pathogens had not been eliminated. Aetiologically epididymitis was caused in one-third of cases each by C. trachomatis (n = 20) and common urinary tract pathogens (n = 20); in the remaining one-third we found N. gonorrhoeae (n = 1). U. urealyticum (n = 3), or no pathogens (n = 26). At the first check-up examination, in 64/70 patients no pathogens were found. Relevant bacteria were still detected in 6 patients: C. trachomatis in 5 and E. aerogenes in 1. After 12 weeks, infection still persisted in 3 patients (E. coli, P. aeruginosa, enterococci). In vitro the microorganisms were invariably sensitive to ofloxacin. Due to abscess formation, surgical intervention became necessary in 6 patients. In 3 of these cases the causative agent was C. trachomatis. Regardless of the aetiology, after 12 weeks, in 20% of our patients the epididymis was still infiltrated and 14% complained of persistent symptoms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120838

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  3 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Tissue penetration of sparfloxacin in a rat model of experimental Escherichia coli epididymitis.

Authors:  M Ludwig; C A Jantos; S Wolf; M Bergmann; K Failing; H G Schiefer; W Weidner
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

3.  Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.

Authors:  E Vieler; C Jantos; H L Schmidts; W Weidner; H G Schiefer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.